Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 CAD | +0.74% | -3.52% | +53.93% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 160.4 | 70.87 | 50.91 | 78.54 | - |
Enterprise Value (EV) 1 | 160.4 | 70.87 | 50.91 | 78.54 | 78.54 |
P/E ratio | -7.21 x | - | - | - | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | 0.31 x | 0.2 x | 0.27 x | 0.24 x |
EV / Revenue | - | 0.31 x | 0.2 x | 0.27 x | 0.24 x |
EV / EBITDA | - | 11.1 x | 2.33 x | 2.59 x | 2.07 x |
EV / FCF | - | -8.36 x | - | 7.77 x | 5.14 x |
FCF Yield | - | -12% | - | 12.9% | 19.4% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 57,093 | 57,155 | 57,206 | 57,331 | - |
Reference price 2 | 2.810 | 1.240 | 0.8900 | 1.370 | 1.370 |
Announcement Date | 3/21/22 | 3/29/23 | 3/26/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 63.31 | - | 226.4 | 259.3 | 286.9 | 328.1 |
EBITDA 1 | - | - | 6.412 | 21.83 | 30.32 | 37.89 |
EBIT | - | - | -7.542 | - | - | - |
Operating Margin | - | - | -3.33% | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income | -2.073 | -20.61 | - | - | - | - |
Net margin | -3.27% | - | - | - | - | - |
EPS | - | -0.3900 | - | - | - | - |
Free Cash Flow 1 | - | - | -8.473 | - | 10.1 | 15.27 |
FCF margin | - | - | -3.74% | - | 3.52% | 4.65% |
FCF Conversion (EBITDA) | - | - | - | - | 33.32% | 40.29% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/13/21 | 3/21/22 | 3/29/23 | 3/26/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 38.66 | 47.6 | 49.83 | 56.3 | 58.91 | 61.38 | - | 67.4 | 68.63 | 70.28 | 72.48 | 75.53 |
EBITDA 1 | -1.022 | 0.012 | -0.174 | 2.104 | 2.279 | 2.203 | - | 6.391 | 7.072 | 7.456 | 8.066 | 7.73 |
EBIT | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | -1.37 | - | - | 2.097 | - | - | - | - | - |
Net margin | - | - | - | -2.43% | - | - | - | - | - | - | - | - |
EPS | - | - | - | -0.0200 | - | - | 0.0400 | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/10/21 | 3/21/22 | 5/9/22 | 8/12/22 | 11/8/22 | 3/29/23 | 11/8/23 | 3/26/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -8.47 | - | 10.1 | 15.3 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | - | 8.41 | - | 3.94 | 5.17 |
Capex / Sales | - | - | 3.71% | - | 1.37% | 1.58% |
Announcement Date | 4/13/21 | 3/21/22 | 3/29/23 | 3/26/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+53.93% | 57.54M | |
+11.70% | 2.88B | |
+15.65% | 1.71B | |
+84.99% | 626M | |
+27.70% | 158M | |
+10.03% | 105M | |
-1.75% | 102M |
- Stock Market
- Equities
- NOVC Stock
- Financials Nova Cannabis Inc.